Calidi Biotherapeutics, Inc.
Recent Filings
All 376 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 27, 2026 |
| 8-K | 8-K | Mar 27, 2026 |
| 8-K | 8-K | Mar 11, 2026 |
| SCHEDULE 13D | — | Mar 9, 2026 |
| 424B5 | 424B5 | Mar 9, 2026 |
| 424B5 | 424B5 | Mar 6, 2026 |
| S-3MEF | S-3MEF | Mar 5, 2026 |
| SCHEDULE 13G/A | — | Feb 10, 2026 |
| 8-K | 8-K | Feb 10, 2026 |
| SCHEDULE 13G | — | Feb 4, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Camaisa Allan | — | Sale | 850 @ $1.46 | 76,952 | Dec 12, 2025 |
| Jackson Andrew C. | Chief Financial Officer | Purchase | 2,500 @ $2.00 | 2,500 | Aug 21, 2025 |
| Leftwich Scott | — | Purchase | 125,000 @ $2.00 | 130,650 | Aug 21, 2025 |
| Poma Eric E | Chief Executive Officer | Purchase | 25,000 @ $2.00 | 25,000 | Aug 21, 2025 |
| Schoeneck James A | — | Purchase | 75,000 @ $2.00 | 76,134 | Aug 21, 2025 |
| Stewart Alan R. | — | Award / Grant | 12,771 | 28,976 | Dec 31, 2024 |
| Leftwich Scott | — | Award / Grant | 11,684 | 67,774 | Dec 31, 2024 |
| Camaisa Allan | CEO and Chairman of the Board | Sale | 10,000 @ $1.62 | 66,712 | Dec 17, 2024 |
| Camaisa Allan | CEO and Chairman of the Board | Award / Grant | 70,155 @ $1.15 | 76,712 | Sep 26, 2024 |
| Leftwich Scott | — | Award / Grant | 67,187 | 560,873 | Jun 28, 2024 |